Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax ‘3’ Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety

References

• Bang OY. Intracranial atherosclerosis: current understanding and perspectives. J Stroke. 2014;16(1):27–35.
   PubMed Web of Science ®Google Scholar
• Vellimana AK, Ford AL, Lee JM, et al. Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management. Neurosurg Focus. 2011;30(6):E14.
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–1316.
   PubMed Web of Science ®Google Scholar
• Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66(8):1187–1191.
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;49(3):e46–e110.
   PubMed Web of Science ®Google Scholar
• Sundt TM Jr., Smith HC, Campbell JK, et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc. 1980;55(11):673–680.
   PubMed Web of Science ®Google Scholar
• Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003.
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240–1248.
   PubMed Web of Science ®Google Scholar
• Alexander MJ, Zauner A, Chaloupka JC, et al. WAEVE trial final results in 152 on-label patients. Stroke. 2019;50(4):889–894.
   Web of Science ®Google Scholar
• Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37(4):1016–1020.
   PubMed Web of Science ®Google Scholar
• Wojak JC, Dunlap DC, Hargrave KR, et al. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27(9):1882–1892.
   PubMed Web of Science ®Google Scholar
• Wolfe TJ, Fitzsimmons BF, Hussain SI, et al. Long term clinical and angiographic outcomes with the Wingspan stent for treatment of symptomatic 50–99% intracranial atherosclerosis: single center experience in 51 cases. J Neurointerv Surg. 2009;1(1):40–43.
   PubMed Web of Science ®Google Scholar
• Papafaklis MI, Chatzizisis YS, Naka KK, et al. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy. Pharmacol Ther. 2012;134(1):43–53.
   PubMed Web of Science ®Google Scholar
• Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96(2):636–645.
   PubMed Web of Science ®Google Scholar
• Jackson D, Tong D, Layland J. A review of the coronary applications of the drug coated balloon. Int J Cardiol. 2017;226:77–86.
   PubMed Web of Science ®Google Scholar
• Gao L, Chen YD. Application of drug-coated balloon in coronary artery intervention: challenges and opportunities. J Geriatr Cardiol. 2016;13(11):906–913.
   PubMedGoogle Scholar
• Jeger RV, Farah A, Ohlow MA, et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet. 2018;392(10150):849–856.
   PubMed Web of Science ®Google Scholar
• Gupta R, Al-Ali F, Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37(10):2562–2566.
   PubMed Web of Science ®Google Scholar
• Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36(12):e165–168.
   PubMed Web of Science ®Google Scholar
• Vajda Z, Aguilar M, Göhringer T, et al. Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency. Clin Neuroradiol. 2012;22(3):227–233.
   PubMed Web of Science ®Google Scholar
• Kurre W, Aguilar-Perez M, Fischer S, et al. Solving the issue of restenosis after stenting of intracranial stenoses: experience with two thin-strut drug-eluting stents (DES)-taxus element and resolute integrity. Cardiovasc Intervent Radiol. 2015;38(3):583–591.
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Castonguay AC, Nguyen TN, et al. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the international stroke conference. J Neurointerv Surg. 2014;6(3):225–230.
   PubMed Web of Science ®Google Scholar
• Luo J, Wang T, Gao P, et al. Endovascular treatment of intracranial atherosclerotic stenosis: current debates and future prospects. Front Neurol. 2018;9:666.
   PubMed Web of Science ®Google Scholar
• Tesfamariam B. Local arterial wall drug delivery using balloon catheter system. J Control Release. 2016;238:149–156.
   PubMed Web of Science ®Google Scholar
• McTaggart RA, Marks MP. The case for angioplasty in patients with symptomatic intracranial atherosclerosis. Front Neurol. 2014;5:36.
   PubMed Web of Science ®Google Scholar
• Dumont TM, Sonig A, Mokin M, et al. Submaximal angioplasty for symptomatic intracranial atherosclerosis: a prospective phase I study. J Neurosurg. 2016;125(4):964–971.
   PubMed Web of Science ®Google Scholar
• Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 2001;104(5):600–605.
   PubMed Web of Science ®Google Scholar
• Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48(12):2584–2591.
   PubMed Web of Science ®Google Scholar
• Kleber FX, Rittger H, Bonaventura K, et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol. 2013;102(11):785–797.
   PubMed Web of Science ®Google Scholar
• Katsanos K, Geisler BP, Garner AM, et al. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open. 2016;6(5):e011245.
   PubMed Web of Science ®Google Scholar
• Gruber P, Garcia-Esperon C, Berberat J, et al. Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience. J Neurointerv Surg. 2018;10(12):e32.
   PubMed Web of Science ®Google Scholar
• Gruber P, Braun C, Kahles T, et al. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study. J Neurointerv Surg. 2019;11(7):719–722.
   Web of Science ®Google Scholar
• Han J, Zhang J, Zhang X, et al. Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome. J Neurointerv Surg. 2019;11(6):569–573.
   Web of Science ®Google Scholar
• Zheng M, Song Y, Zhang J, et al. Endovascular recanalization of non-acute symptomatic middle cerebral artery total occlusion and its short-term outcomes. Front Neurol. 2019;10:484.
   PubMed Web of Science ®Google Scholar
• Vajda Z, Guthe T, Perez MA, et al. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol. 2011;32(10):1942–1947.
   PubMed Web of Science ®Google Scholar
• Aachen Resonance. Neuro Elutax. [cited 2019 Sept 22]. Available from: http://www.1amedical.org/wp-content/uploads/2014/04/Elutax_SV_NEURO_Broschüre
   Google Scholar
• AR Baltic Medical. Elutax “3” Neuro. [cited 2019 Sept 22]. Available from: http://www.arbalticmedical.com/products
   Google Scholar
• b.braun. SeQuent Please NEO. [cited 2019 Sept 22]. Available from: https://www.bbraun.com/en/products/b2/sequent-please-neo.html
   Google Scholar
• Cloft HJ, Lynn MJ, Feldmann E, et al. Risk of cerebral angiography in patients with symptomatic intracranial atherosclerotic stenosis. Cerebrovasc Dis. 2011;31(6):588–591.
   PubMed Web of Science ®Google Scholar
• Wong JM, Ziewacz JE, Panchmatia JR, et al. Patterns in neurosurgical adverse events: endovascular neurosurgery. Neurosurg Focus. 2012;33(5):E14.
   PubMed Web of Science ®Google Scholar